Gemcitabine-induced radiation recall dermatitis: case report
Related Experiment Video
Updated: Jul 30, 2026
11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
G Bar-Sela1, A Beny, R Bergman
1Department of Oncology, Rambam Medical Center and Faculty of Medicine, Technion-Israel Institute of Technology, Haifa. bar_sela@rambam.health.gov.il
Tumori
|May 7, 2002
Abstract:
A 65-year-old male with lung adenocarcinoma received radiotherapy to the mediastinum and right upper lobe, followed by chemotherapy with gemcitabine. Radiation recall dermatitis developed in the area corresponding to the radiotherapy portal. This is one of just a few cases reported recently concerning radiation recall dermatitis stemming from gemcitabine.
